Involvement of spinal and supraspinal structures in tizanidine-induced antinociceptive action

Toshitaka Nabeshima, Kiyoshi Matsuno, Tsutomu Kameyama

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The site of action of tizanidine (5-chloro-4-(2-imidazolin-2-yl-amino)2,1,3-benzothiadiazole) was investigated in a tail-flick test in comparison with clonidine and morphine. Tizanidine and clonidine produced a profound and linear dose-dependent antinociceptive action by i.c.v. administration. The ED511 values for tizanidine, clonidine and morphine were increased 2-4-fold 1 or 3 days after spinalization at C5-C6. These results indicate that the antinociceptive activity of tizanidine arises mainly from activity at the supraspinal level, similar to clonidine and morphine, but these drugs act also at the spinal level at high doses.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalNeuroscience Letters
Volume63
Issue number1
DOIs
Publication statusPublished - 02-01-1986
Externally publishedYes

Fingerprint

Clonidine
Morphine
tizanidine
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{512c44bc6cf046bf8cce1740cbf3daa9,
title = "Involvement of spinal and supraspinal structures in tizanidine-induced antinociceptive action",
abstract = "The site of action of tizanidine (5-chloro-4-(2-imidazolin-2-yl-amino)2,1,3-benzothiadiazole) was investigated in a tail-flick test in comparison with clonidine and morphine. Tizanidine and clonidine produced a profound and linear dose-dependent antinociceptive action by i.c.v. administration. The ED511 values for tizanidine, clonidine and morphine were increased 2-4-fold 1 or 3 days after spinalization at C5-C6. These results indicate that the antinociceptive activity of tizanidine arises mainly from activity at the supraspinal level, similar to clonidine and morphine, but these drugs act also at the spinal level at high doses.",
author = "Toshitaka Nabeshima and Kiyoshi Matsuno and Tsutomu Kameyama",
year = "1986",
month = "1",
day = "2",
doi = "10.1016/0304-3940(86)90002-9",
language = "English",
volume = "63",
pages = "1--4",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Involvement of spinal and supraspinal structures in tizanidine-induced antinociceptive action. / Nabeshima, Toshitaka; Matsuno, Kiyoshi; Kameyama, Tsutomu.

In: Neuroscience Letters, Vol. 63, No. 1, 02.01.1986, p. 1-4.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Involvement of spinal and supraspinal structures in tizanidine-induced antinociceptive action

AU - Nabeshima, Toshitaka

AU - Matsuno, Kiyoshi

AU - Kameyama, Tsutomu

PY - 1986/1/2

Y1 - 1986/1/2

N2 - The site of action of tizanidine (5-chloro-4-(2-imidazolin-2-yl-amino)2,1,3-benzothiadiazole) was investigated in a tail-flick test in comparison with clonidine and morphine. Tizanidine and clonidine produced a profound and linear dose-dependent antinociceptive action by i.c.v. administration. The ED511 values for tizanidine, clonidine and morphine were increased 2-4-fold 1 or 3 days after spinalization at C5-C6. These results indicate that the antinociceptive activity of tizanidine arises mainly from activity at the supraspinal level, similar to clonidine and morphine, but these drugs act also at the spinal level at high doses.

AB - The site of action of tizanidine (5-chloro-4-(2-imidazolin-2-yl-amino)2,1,3-benzothiadiazole) was investigated in a tail-flick test in comparison with clonidine and morphine. Tizanidine and clonidine produced a profound and linear dose-dependent antinociceptive action by i.c.v. administration. The ED511 values for tizanidine, clonidine and morphine were increased 2-4-fold 1 or 3 days after spinalization at C5-C6. These results indicate that the antinociceptive activity of tizanidine arises mainly from activity at the supraspinal level, similar to clonidine and morphine, but these drugs act also at the spinal level at high doses.

UR - http://www.scopus.com/inward/record.url?scp=0022637558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022637558&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(86)90002-9

DO - 10.1016/0304-3940(86)90002-9

M3 - Article

VL - 63

SP - 1

EP - 4

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -